Replimune Group Inc (REPL) stock is currently valued at $10.32. During the last session, the stock experienced a remarkable rise, reaching $11.39 after opening at $10.92. The stock briefly dropped to $10.26 before ultimately closing at $11.16.
Replimune Group Inc experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $29.52 on 02/02/23, while the lowest price for the same period was registered at $10.42 on 11/16/23.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
52-week price history of REPL Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Replimune Group Inc’s current trading price is -65.04% away from its 52-week high, while its distance from the 52-week low is -0.96%. The stock’s price range during this period has spanned from $10.42 to $29.52. In the Healthcare sector, the Replimune Group Inc’s shares surpassed a trading volume of approximately 0.74 million for the day, which was noticeably higher compared to the average daily volume of 9.0.66 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Replimune Group Inc (REPL) has experienced a quarterly decline of -46.91% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 609.50M and boasts a workforce of 284 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 17.78, with a change in price of -12.97. Similarly, Replimune Group Inc recorded 604,012 in trading volume during the last 100 days, posting a change of -55.69%.
Examining REPL’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for REPL stands at 0.13. Similarly, the long-term debt-to-equity ratio is also 0.12.
REPL Stock Stochastic Average
Today’s raw stochastic average for Replimune Group Inc over the last 50 days is 0.61%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 1.18%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 10.85% and 11.14%, respectively.
REPL Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. Until today this year the stock’s price performance recorded a decrease of -62.06%. However, over the last six months, the performance has been stronger by -47.45%. The price of REPL decreased -27.88% over the last 30 days. And in the last five days, it has fallen by -10.10%.
